Early treatment with dornase alfa in cystic fibrosis: what are the issues?

Pediatr Pulmonol. 1998 Feb;25(2):79-82. doi: 10.1002/(sici)1099-0496(199802)25:2<79::aid-ppul1>3.0.co;2-i.
No abstract available

Publication types

  • Comment
  • Editorial

MeSH terms

  • Adolescent
  • Child
  • Cystic Fibrosis / drug therapy*
  • Cystic Fibrosis / physiopathology
  • Deoxyribonuclease I / therapeutic use*
  • Expectorants / therapeutic use*
  • Humans
  • Infant
  • Recombinant Proteins / therapeutic use
  • Respiratory Mechanics

Substances

  • Expectorants
  • Recombinant Proteins
  • DNASE1 protein, human
  • Deoxyribonuclease I